PF-Atlas › Mechanisms › WNT/AEC2 Expansion

WNT/AEC2 Expansion in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

WNT/AEC2 Expansion is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 1 clinical trial acting through this mechanism.

Drugs targeting WNT/AEC2 Expansion

ENTR-01

Clinical trials

ENTR-01 — ENTR-01-IPF

Medical disclaimer. This is a research summary, not medical advice.